← back to search

Markus Zeitlinger

Zero to Three · AT
🔎 Find collaborators in Pharmacology · Molecular Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pharmacology · Molecular Medicine
Research interest
Research interests include Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria, Drug Transport and Resistance Mechanisms, and Antimicrobial Resistance in Staphylococcus.
h-index
47
citations
9,862
works
449
NIH funding
primary concept
Medicine
email

Recent publications

Immediate versus staged revascularization in acute coronary syndrome and multivessel disease: a meta-analysis and meta-regression of RCTs.
2026cited by 0position: contributordoi
Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension (SHAMROC): an open-label, randomized controlled trial.
2026cited by 0position: contributordoi
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
Annals of the Rheumatic Diseases 2025cited by 25position: middledoi
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU study.
2025cited by 23position: contributordoi
Evaluation of the need for dosing adaptations in obese patients for surgical antibiotic prophylaxis: a model-based analysis of cefazolin pharmacokinetics
British Journal of Anaesthesia 2025cited by 7position: middledoi
Generics, Biosimilars and Follow‐On Non‐Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists
European Journal of Neurology 2025cited by 4position: middledoi
Surgical Antibiotic Prophylaxis Dosing in Adult Patients with Obesity: A Comprehensive Review of Pharmacokinetic and Pharmacodynamic Data
Anesthesiology 2025cited by 3position: middledoi
Impact of Hypothermic Temperature Control on Plasma and Soft Tissue Pharmacokinetics of Penicillin/Beta-Lactamase Inhibitor Combinations in Patients Resuscitated After Cardiac Arrest
Clinical Pharmacokinetics 2025cited by 1position: lastdoi
Interspecies differences in plasma protein binding of beta-lactam antibiotics
International Journal of Antimicrobial Agents 2025cited by 1position: lastdoi
Surgical Antibiotic Prophylaxis Dosing in Adult Patients with Obesity: A Comprehensive Review of Pharmacokinetic and Pharmacodynamic Data.
2025cited by 1position: contributordoi
Variable temocillin protein binding and pharmacokinetics in different clinical conditions: Implications for target attainment.
2025cited by 1position: contributordoi
Cerebral Ischemia Protection After Aneurysmal Subarachnoid Hemorrhage: CSF Nimodipine Levels After Intravenous Versus Oral Nimodipine Administration.
2025cited by 1position: contributordoi
Functional MRP1 activity in human skeletal muscle.
2025cited by 0position: contributordoi
Single-dose and steady-state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug-drug interaction study.
2025cited by 0position: contributordoi
Continuous Intravenous Nimodipine Infusion With Ethanol as Carrier in Aneurysmal Subarachnoid Hemorrhage Does Not Result in Measurable Cerebral Ethanol Levels.
2025cited by 0position: contributordoi
Liposomal Bupivacaine for Peripheral Nerve Blockade: A Randomized, Controlled, Crossover, Triple-blinded Pharmacodynamic Study in Volunteers.
2024cited by 14position: contributordoi
Target-site cefiderocol pharmacokinetics in soft tissues of healthy volunteers
Journal of Antimicrobial Chemotherapy 2024cited by 7position: middledoi
Linezolid brain penetration in neurointensive care patients
Journal of Antimicrobial Chemotherapy 2024cited by 6position: lastdoi
Impact of pH on the activity of novel cephalosporin cefiderocol in human urine.
2024cited by 4position: contributordoi
Interspecies variability in protein binding of antibiotics basis for translational PK/PD studies-a case study using cefazolin.
2024cited by 4position: contributordoi
Effect of albumin substitution on pharmacokinetics of piperacillin/tazobactam in patients with severe burn injury admitted to the ICU.
2024cited by 3position: contributordoi
Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections.
2024cited by 2position: contributordoi
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment.
2024cited by 1position: contributordoi
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors.
2024cited by 1position: contributordoi
Challenges in assessing the immunization status of adults in Germany-lessons from a population-based VACCELERATE survey on polio vaccination.
2024cited by 1position: contributordoi
Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infections.
2024cited by 0position: contributordoi
Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics
Travel Medicine and Infectious Disease 2023cited by 27position: middledoi
Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials.
2023cited by 16position: contributordoi
Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: A non-inferiority meta-analysis of 6 randomised controlled trials.
2023cited by 12position: contributordoi
Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data.
2023cited by 6position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 35 papers (2020–2026)Christoph Dorn · University of Regensburg27 papers (2017–2025)Oliver Langer · Medical University of Vienna12 papers (2019–2025)David Petroff · University of Tübingen11 papers (2019–2025)Philipp Simon · Edwards Lifesciences (Switzerland)11 papers (2019–2025)Hermann Wrigge · University of Nevada, Las Vegas11 papers (2019–2025)Charlotte Kloft · Freie Universität Berlin10 papers (2019–2025)Frieder Kees · University of Regensburg10 papers (2017–2024) · 9 papers (2021–2025) · 9 papers (2018–2025)Alexander Kratzer · University of Regensburg8 papers (2018–2022) · 8 papers (2021–2025)Arne Dietrich · University Hospital Heidelberg8 papers (2019–2021)David Petroff · Leipzig University7 papers (2019–2025) · 6 papers (2018–2025)David Busse · Freie Universität Berlin6 papers (2020–2025)Anselm Jorda · BMJ Publishing Group6 papers (2022–2026)Bernd Jilma · Universitätszahnklinik Wien6 papers (2020–2026)Helmuth Haslacher · Zentrum für Labormedizin5 papers (2019–2022)Sebastian G. Wicha · Universität Hamburg5 papers (2020–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pharmacology · Molecular Medicine →